Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2015

01-06-2015 | Original Article

Soft tissue reactions in patients with bone anchored hearing aids

Author: J. Rebol

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2015

Login to get access

Abstract

Aims

To establish the incidence and correlation between the degree of soft tissue reaction and the body mass index (BMI) according to age and gender after a bone anchored hearing aid (BAHA) implant.

Methods

We did a 1–9-year follow-up for the all the patients who underwent surgery in our department with BAHA implant system. Soft tissue reactions were classified in accordance with the Holgers classification on regular patient visits. BMI was calculated for each patient, and changes were recorded at least once a year.

Results

47 patients were evaluated. 58 % were operated on for chronic otitis with mixed or conductive hearing loss; 20 % had unilateral or bilateral atresia and 16 % had single sided deafness (SSD); other indications were otosclerosis and syndromic patients. The grade of Holgers classification significantly correlated at a 0.001 level with BMI (Spearmans rho 0.452). Holgers grade also differed significantly between the sexes–skin reactions in females were less frequent. An ANOVA test did not reveal any statistical difference between patients with dissimilar indications for BAHA.

Conclusion

If performed carefully, BAHA surgery produces a favorable outcome. The Holgers grade may change as time passes. If skin reactions appear, they can be treated through local or systemic therapy, and they may turn into a normal grade. Adipose patients should be treated with special care because they are more prone to soft tissue reactions.
Literature
1.
go back to reference Tjellström A, Håkansson B (1995) The bone-anchored hearing aid. Design principles, indications and long-term clinical results. Otolaryngol Clin North Am 28(1):53–72PubMed Tjellström A, Håkansson B (1995) The bone-anchored hearing aid. Design principles, indications and long-term clinical results. Otolaryngol Clin North Am 28(1):53–72PubMed
2.
go back to reference Tjellström A, Granström G (2006) How we do it: frequency of skin necrosis after BAHA surgery. Clin Otolaryngol 31:216–232CrossRefPubMed Tjellström A, Granström G (2006) How we do it: frequency of skin necrosis after BAHA surgery. Clin Otolaryngol 31:216–232CrossRefPubMed
3.
go back to reference De Wolf MJF, Hol MKS, Mylanus EAM, Cremers C (2009) Bone-anchored hearing aid surgery in older adults: implant loss and skin reactions. Ann Otol Rhinol Laryngol 118(7):525–531CrossRefPubMed De Wolf MJF, Hol MKS, Mylanus EAM, Cremers C (2009) Bone-anchored hearing aid surgery in older adults: implant loss and skin reactions. Ann Otol Rhinol Laryngol 118(7):525–531CrossRefPubMed
4.
go back to reference Wazen JJ, Young DL, Farrugia MC et al (2008) Successes and complications of the BAHA system. Otol Neurotol 29:1115–1119CrossRefPubMed Wazen JJ, Young DL, Farrugia MC et al (2008) Successes and complications of the BAHA system. Otol Neurotol 29:1115–1119CrossRefPubMed
5.
go back to reference Holgers KM, Tjellström A, Bjursten LM, Erlandson BE (1988) Soft tissue reactions around percutaneous implants: a clinical study of soft tissue conditions around skin penetrating titanium implants for bone anchored hearing aids. Am J Otol 9:56–59PubMed Holgers KM, Tjellström A, Bjursten LM, Erlandson BE (1988) Soft tissue reactions around percutaneous implants: a clinical study of soft tissue conditions around skin penetrating titanium implants for bone anchored hearing aids. Am J Otol 9:56–59PubMed
6.
go back to reference Holgers KM (2000) Characteristics of the inflammatory process around skin-penetrating titanium implants for aural rehabilitation. Audiology 39:253–259CrossRefPubMed Holgers KM (2000) Characteristics of the inflammatory process around skin-penetrating titanium implants for aural rehabilitation. Audiology 39:253–259CrossRefPubMed
7.
go back to reference Dun CA, de Wolf MJ, Hol MK, Wigren S, Eeg-Olofsson M, Green K et al (2011) Stability, survival, and tolerability of a novel Baha implant system: six-month data from a multicenter clinical investigation. Otol Neurotol 32(6):1001–1007CrossRefPubMed Dun CA, de Wolf MJ, Hol MK, Wigren S, Eeg-Olofsson M, Green K et al (2011) Stability, survival, and tolerability of a novel Baha implant system: six-month data from a multicenter clinical investigation. Otol Neurotol 32(6):1001–1007CrossRefPubMed
8.
go back to reference Bray GA (1987) Overweight is risking fate. Definition, classification, prevalence and risks. Ann N Y Sci 499:14–28CrossRef Bray GA (1987) Overweight is risking fate. Definition, classification, prevalence and risks. Ann N Y Sci 499:14–28CrossRef
9.
go back to reference Wazen JJ, Wycherly B, Daugherty J (2011) Complication of bone–anchored hearing devices. In: Kompis M, Caversaccio M (eds) Implantable hearing aids. Adv Otorhinolaryngol Karger Basel vol 71, pp 63–72 Wazen JJ, Wycherly B, Daugherty J (2011) Complication of bone–anchored hearing devices. In: Kompis M, Caversaccio M (eds) Implantable hearing aids. Adv Otorhinolaryngol Karger Basel vol 71, pp 63–72
10.
go back to reference Ricci G, Della Volpe A, Faralli M, Longari F, Gulla M, Mansi N, Frenguelli A (2010) Results and complications of the BAHA system (bone anchored hearing aid). Eur Arch Otorhinolaryngol 267:1539–1545CrossRefPubMed Ricci G, Della Volpe A, Faralli M, Longari F, Gulla M, Mansi N, Frenguelli A (2010) Results and complications of the BAHA system (bone anchored hearing aid). Eur Arch Otorhinolaryngol 267:1539–1545CrossRefPubMed
11.
go back to reference Mudry A (2009) Bone anchored hearing aids (BAHA): skin healing process for skin flap technique versus linear incision technique in the first three months after the implantation. Rev Laryngol Otol Rhinol 130(5):281–284 Mudry A (2009) Bone anchored hearing aids (BAHA): skin healing process for skin flap technique versus linear incision technique in the first three months after the implantation. Rev Laryngol Otol Rhinol 130(5):281–284
12.
go back to reference de Wolf MJF, Hol MKS, Huygen PLM, Mylanus EAM, Cremers CWRJ (2008) Clinical outcome of the simplified surgical technique for BAHA implication. Otol Neurotol 29(8):1100–1108CrossRefPubMed de Wolf MJF, Hol MKS, Huygen PLM, Mylanus EAM, Cremers CWRJ (2008) Clinical outcome of the simplified surgical technique for BAHA implication. Otol Neurotol 29(8):1100–1108CrossRefPubMed
14.
go back to reference Russel L (2001) The importance of patients’ nutritional status in wound healing. Br J Nurs 10(6 (Suppl)):44–49 Russel L (2001) The importance of patients’ nutritional status in wound healing. Br J Nurs 10(6 (Suppl)):44–49
15.
go back to reference Berenholz LP, Burkey JM, Lippy WH (2010) High body mass index as a risk factor for skin overgrowth with the bone—anchored hearing aid. Otol Neurotol 31:430–432CrossRefPubMed Berenholz LP, Burkey JM, Lippy WH (2010) High body mass index as a risk factor for skin overgrowth with the bone—anchored hearing aid. Otol Neurotol 31:430–432CrossRefPubMed
16.
go back to reference Reyes RA, Tjellstroem A, Granstroem G (2000) Evaluation of implant losses and skin reactions around extraoral bone-anchored implants: a 0- to 8-year follow-up. Otolaryngol Head Neck Surg 122(2):272–276CrossRefPubMed Reyes RA, Tjellstroem A, Granstroem G (2000) Evaluation of implant losses and skin reactions around extraoral bone-anchored implants: a 0- to 8-year follow-up. Otolaryngol Head Neck Surg 122(2):272–276CrossRefPubMed
17.
go back to reference Monksfield P, Ho EC, Reid A, Proops D (2009) Experience with the longer (8.5 mm) abutment for bone-anchored hearing aid. Otol Neurotol 30:274–276CrossRefPubMed Monksfield P, Ho EC, Reid A, Proops D (2009) Experience with the longer (8.5 mm) abutment for bone-anchored hearing aid. Otol Neurotol 30:274–276CrossRefPubMed
18.
go back to reference Monksfield P, Chapple ILC, Matthews JB, Grant MM, Addison O, Reid AP, Proops DW, Sammons RL (2011) Biofilm formation on bone anchored hearing aids. J Laryngol Otol 125:1125–1130CrossRefPubMed Monksfield P, Chapple ILC, Matthews JB, Grant MM, Addison O, Reid AP, Proops DW, Sammons RL (2011) Biofilm formation on bone anchored hearing aids. J Laryngol Otol 125:1125–1130CrossRefPubMed
19.
go back to reference Hultcrantz M (2011) Outcome of the bone-anchored hearing aid procedure without skin thinning: a prospective clinical trial. Otol Neurotol 32(7):1134–1139CrossRefPubMed Hultcrantz M (2011) Outcome of the bone-anchored hearing aid procedure without skin thinning: a prospective clinical trial. Otol Neurotol 32(7):1134–1139CrossRefPubMed
20.
go back to reference Larsson A, Wigren S, Andersson M, Flynn M, Nannmark U (2012) Histologic evaluation of soft tissue integration of experimental abutments for bone anchored hearing implants using surgery without soft tissue reduction. Otol Neurotol 33(8):1445–1451CrossRefPubMed Larsson A, Wigren S, Andersson M, Flynn M, Nannmark U (2012) Histologic evaluation of soft tissue integration of experimental abutments for bone anchored hearing implants using surgery without soft tissue reduction. Otol Neurotol 33(8):1445–1451CrossRefPubMed
21.
go back to reference Hol MK, Nelissen RC, Agterberg MJ, Cremers CW, Snik AF (2013) Comparison between a new implantable transcutaneous bone conductor and percutaneous bone-conduction hearing implant. Otol Neurotol 34(6):1071–1075CrossRefPubMed Hol MK, Nelissen RC, Agterberg MJ, Cremers CW, Snik AF (2013) Comparison between a new implantable transcutaneous bone conductor and percutaneous bone-conduction hearing implant. Otol Neurotol 34(6):1071–1075CrossRefPubMed
Metadata
Title
Soft tissue reactions in patients with bone anchored hearing aids
Author
J. Rebol
Publication date
01-06-2015
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2015
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-014-1151-y

Other articles of this Issue 2/2015

Irish Journal of Medical Science (1971 -) 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine